Skip to main content
Events •

At What Price: Determining Pharmaceutical Prices in Medicare

A complex array of government policies and market forces cause drug prices to be higher in the United States than other nations. Is this a problem? If so, are there better policies for determining drug prices? What is the “right” price for a drug? Panelists will discuss evidence suggesting that US drug prices are excessive and what policymakers should and should not do in response.

Featuring
Pragya Kakani
Pragya Kakani

Assistant Professor of Population Health Sciences, Weill Cornell Medical School

Luca Maini cropped
Luca Maini

Assistant Professor of Health Care Policy, Harvard Medical School